Closing Bell: Nervgen Pharma Corp up on Tuesday (NGEN)

Nervgen Pharma Corp opened trading today at $2.44 and closed at $2.50. Intraday prices ranged from a low of $2.38 to a high of $2.61.

Share prices boosted 3.31 percent from the previous day's close of $2.42.

Today across North America, the TSX Composite closed -0.28% at 21788.48, the S&P 500 closed -0.31% at 5447.87, the Dow Jones Industrial Average closed 0.67% at 39411.21 and the Nasdaq Composite closed -1.09% at 17496.82.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

Trading volume was 156,536 on 241 total trades, while having an average volume of 63,936 over the last 5-days.

The TSX-V overall saw 1,735 price advancers against 3,477 declines and 116 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 12 months, Nervgen Pharma Corp's shares have boosted 54.32%, while in 2024, they have dipped -7.41%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $169.22 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Nervgen Pharma Corp's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..